Treatment of Trichomoniasis Vaginal Infection
First-Line Treatment Options
- The Centers for Disease Control and Prevention recommends metronidazole 500 mg orally twice daily for 7 days as the preferred regimen for trichomoniasis vaginal infection, with cure rates of approximately 90-95% 1
Management of Sex Partners
- The Centers for Disease Control and Prevention and MMWR Recommendations and Reports suggest that all sex partners should be treated simultaneously to prevent reinfection, and patients should avoid sexual intercourse until both they and their partners have completed treatment and are asymptomatic 1, 2
Special Populations
Pregnancy
- The MMWR Recommendations and Reports state that metronidazole is contraindicated during the first trimester of pregnancy, but after the first trimester, pregnant women can be treated with metronidazole 2 g orally in a single dose 1, 2, 3
- The American College of Obstetricians and Gynecologists is not mentioned, however, treatment is important as trichomoniasis has been associated with adverse pregnancy outcomes, including premature rupture of membranes and preterm delivery 1, 3
HIV Infection
- The Centers for Disease Control and Prevention recommends that patients with HIV infection should receive the same treatment regimen as HIV-negative individuals 1, 2
Metronidazole Allergy
- The MMWR Recommendations and Reports state that for patients with allergy or intolerance to metronidazole, options are limited as effective alternatives are not readily available 2
- The Centers for Disease Control and Prevention suggests that patients with immediate-type allergy to metronidazole may require desensitization 1
Follow-Up Recommendations
- The MMWR Recommendations and Reports suggest that routine follow-up is unnecessary for patients who become asymptomatic after treatment, but if symptoms persist, patients should be re-evaluated 1, 2
Treatment Failure Management
- The Centers for Disease Control and Prevention and MMWR Recommendations and Reports recommend that for first treatment failure, re-treat with metronidazole 500 mg twice daily for 7 days, and for repeated failure, administer metronidazole 2 g once daily for 3-5 days 1, 2
- The MMWR Recommendations and Reports suggest that if treatment continues to fail and reinfection has been excluded, consult with an infectious disease specialist 2
CDC Guidelines for Metronidazole Use in Trichomoniasis
Alternative Treatment Regimens
- The CDC lists a single‑dose regimen of metronidazole 2 g taken orally as an acceptable alternative when adherence to a multi‑day course is uncertain. 4
- An FDA‑approved option of Flagyl 375 mg taken orally twice daily for 7 days is mentioned, although data confirming clinical equivalence to the standard regimen are limited. 5
Partner Management
- The CDC recommends that all sexual partners receive simultaneous treatment and that sexual activity be avoided until both partners have completed therapy and are asymptomatic. 4
Management of Treatment Failure
- First failure: Re‑treat with metronidazole 500 mg orally twice daily for 7 days. 4
- Second failure: Administer metronidazole 2 g orally once daily for 3–5 days (supported by both CDC recommendations from 1998 and 2002). [5][4]
- Persistent failure: After excluding reinfection, obtain susceptibility testing and consult an infectious‑disease specialist. 4
Special Populations
Pregnancy
- For pregnant individuals beyond the first trimester, a single oral dose of metronidazole 2 g is recommended. 4
- Earlier CDC guidance (1993) contraindicated metronidazole in the first trimester, but more recent evidence (2002) does not demonstrate consistent teratogenic effects. [6][4]
HIV‑Infected Patients
- The CDC advises using the same metronidazole regimens for HIV‑positive patients as for HIV‑negative patients. 4
Metronidazole Allergy
- Desensitization is the recommended strategy for patients with metronidazole allergy, as no equally effective alternatives exist. 4
- Topical metronidazole formulations achieve cure rates below 50 % and are not recommended for trichomoniasis. 4